Meeting
2016 ASCO Annual Meeting
Improved prognostication using molecular (mol) markers and clinicopathological (clpath) features in high-risk stage II/III colon cancer (CC).
Authors
Rodrigo Dienstmann
Sage Bionetworks, Seattle, WA
Rodrigo Dienstmann , Sabine Tejpar , Frank A. Sinicrope , Amanda I. Phipps , Brian Bot , Stephen Henry Friend , Mauro Delorenzi , Polly A. Newcomb , Daniel J. Sargent , John M Jessup , Justin Guinney
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 34, 2016 (suppl; abstr 3519)
DOI
10.1200/JCO.2016.34.15_suppl.3519
Abstract #
3519
Poster Bd #
216
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability, and CIMP status: Prognostic implications and response to chemotherapy.
First Author: Oscar Murcia Sr.
Poster
2017 Gastrointestinal Cancers Symposium
Effect of colon cancer sidedness compared to tumor biology on stage-specific survival.
First Author: Ahmed Dehal
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The association between KRAS mutational status, clinicopathological factors including the preoperative systemic inflammatory response and outcomes in TNM stage I-III colon cancer.
First Author: Allan Matthew Golder
First Author: Yoo Jin Joung